A Review of the Impact of Stevia Leaf (Stevia rebaudiana Bert.) as a Sweetener in Blood Glucose in Alloxan-Induced Rats
Abstrak
Diabetes mellitus (DM) is a chronic condition characterized by elevated blood glucose levels due to insulin-related deficiencies and is often referred to as “The Silent Killer”. Medicinal plants have been widely explored as alternative therapies for managing DM. Among these, Stevia rebaudiana Bert. has garnered significant attention for its potent antidiabetic properties. Known as a natural sweetener 200–300 times sweeter than sucrose, Stevia boasts a zero glycemic index, making it particularly suitable for individuals with diabetes. This review aims to evaluate the antihyperglycemic potential of Stevia rebaudiana Bert. as an alternative to conventional therapies. A systematic review was conducted by acquiring data from scientific databases such as Semantic Scholar, PubMed, Scopus, OpenAlex, Crossref, and ScienceDirect, focusing on literature published between 2020–2024. Studies on diabetic rat models induced with alloxan were analyzed, with doses ranging from 20–1000 mg/kgBW and optimal doses identified between 120–150 mg/kgBW. The results demonstrated that Stevia significantly reduced blood glucose levels in diabetic rats and sustained hyperglycemia, effectively modeling type 1 diabetes. The bioactive constituents, including phenolics, alkaloids, glycosides, steviosides, flavonoids, and tannins, were identified as key contributors to its antihyperglycemic activity. In conclusion, Stevia rebaudiana Bert. exhibits promising efficacy as a natural antidiabetic agent. Its ability to reduce blood glucose levels and its zero glycemic index position it as a viable alternative to conventional antihyperglycemic therapies, especially for managing type 1 DM.
Kata Kunci
Teks Lengkap:
PDFReferensi
Dilworth L, Facey A, Omoruyi F. Diabetes Mellitus and Its Metabolic Complications: The Role of Adipose Tissues. Int. J. Mol. Sci. 2021;22(14):7644.
Peteliuk V, Rybchuk L, Bayliak M, Storey KB, Luschak O. Natural sweetener Stevia rebaudiana: Functionalities, health benefits and potential risks. EXCLI J. 2021;20:1412-1430.
Schiatti-Sisó IP, Quintana SE, García-Zapateiro LA. Stevia (Stevia rebaudiana) as a common sugar substitute and its application in food matrices: an updated review. J Food Sci Technol. 2022;60(5):1483–1492.
Szkudelski T. The Mechanism of Alloxan and Streptozotocin Action in B Cells of the Rat Pancreas. Physiol. Res. 2001;50:536-546.
Kliber A, Szkudelski T, Chichlowska J. Alloxan stimulation and subsequent inhibition of insulin release from in situ perfused rat pancreas. J Physiol Pharmacol. 1996;47:321-328.
Siso IPS, Quintana SE, Zapateiro LAG. Stevia (Stevia rebaudiana) as a common sugar substitute and its application in food matrices: an updated review. Journal of Food Science and Technology. 2022;60(2).
Pawar RS, Krynitsky AJ, Rader J. Sweeteners from plants-with emphasis on Stevia rebaudiana (Bertoni) and Siraitia grosvenorii (Swingle). Analytical and Bioanalytical Chemistry. 2013;405(13).
Assaei R, Mokarram P, Dastghaib S, et al. Hypoglycemic Effect of Aquatic Extract of Stevia in Pancreas of Diabetic Rats: PPARγ-dependent Regulation or Antioxidant Potential. Avicenna J Med Biotechnol. 2016;8(2):65–74.
Anton SD, Martin CK, Han H, et al. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite. 2010;55(1):37–43.
Misra H, Soni M, Silawat N, Mehta D, Mehta BK, Jain DC. Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats. J Pharm Bioallied Sci. 2011;3:242-8.
Ong KW, Hsu A, Tan BK. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem Pharmacol. 2013;85(9):1341-51.
Unnikrishnan R, Anjana RM, Mohan V. Diabetes mellitus and its complications in India. Nat Rev Endocrinol. 2016;12(6):357-70.
Kim SM, Imm JY. The Effect of chrysin-loaded phytosomes on insulin resistance and blood sugar control in type 2 diabetic db/db mice. Molecules. 2020;25(23):5503.
Dewi NLKAA, Prameswari PND, Cahyaningsih E, Megawati F, Agustini NPD, Juliadi D. Review : Pemanfaatan Tanaman Sebagai Fitoterapi pada Diabetes Mellitus. Jurnal Integrasi Obat Tradisional. 2022;2(1):2963–2161.
Castro DFP, Bernardo NJLC, Matias FBR. Stevia rebaudiana Leaf Extract Reduces Blood Glucose and Visceral Fat Accumulation in Alloxan-Induced Diabetic Mice. 2021;10(5):e3347.
Mutmainah, Martono Y, Puspitaningrum I, Kusmita L. Leaf Extract Microencapsulation of Stevia rebaudiana Bert Using Inulin-Chitosan as Anti-Diabetes Diet. 2020.
Hussain F, Hafeez J. Therapeutic Attributes of Stevia rebaudiana Leaves in Diabetic Animal Model. RADS J Biol Res Appl Sci. 2021;12(1):1-7.
El-Hadary A, Sitohy M. Safely effective hypoglycemic action of stevia and turmeric extracts on diabetic Albino rats. J Food Biochem. 2020;00:e13549.
Eidangbe, George O. Andrological Potential of Aqueous Leaf Extract of Stevia Rebaudiana in Male Wistar Rats. Journal of Complementary and Alternative Medical Research. 2024;25(12):122-32.
Rashid AH, Mohammed MJ, Hussein FF. The Effect of Dried Stevia Leaves on Some Biochemical. Characteristics in the Blood of Diabetic Rats. IOP Conf. Series: Earth and Environmental Science. 2024;1371:062011.
Gupta E, Mohammed A, Mishra N, Purwar S, Rizvi SI, Sundaram S.Antioxidant and anti-diabetic potential of rebaudioside A and a mixture of steviol glycosides in alloxan-induced diabetic rats. Indian Journal of Natural Products and Resources. 2021;12(3):391-399.
Aissaoui O, Terki L, Ameur SA, Bitam A. In vivo evaluation of antioxydant potential and antihyperglycemic effect of Stevia rebaudiana Bertoni. Agronomy Research. 2024;22(1):33-51.
Vílchez LFV, Ascencion JH, Dooley TP. GlucoMedix®, an extract of Stevia rebaudiana and Uncaria tomentosa, reduces hyperglycemia, hyperlipidemia, and hypertension in rat models without toxicity: a treatment for metabolic syndrome. BMC Complementary Medicine and Therapies. 2022;22:62.
Abdillah S, Lestari AG, Monika P, Sumaryono W, Hisyam K. Preliminary Analysis of the Antidiabetic Activity of Indonesian Polyherbal Formulation. Journal of Natural Remedies. 2021;21(3):219-223.
Kumar A, Aswal S, Semwal RB, Chauhan A, Joshi SK, Semwal DK. Role of plant-derived alkaloids against diabetes and diabetes-related complications: a mechanism-based approach. Phytochemistry Reviews. 2019;18(5):1277–1298.
Muhammad I, Rahman N, Gul-E-nayab, Nishan U, Shah M. Antidiabetic activities of alkaloids isolated from medicinal plants. Brazilian Journal of Pharmaceutical Sciences. 2021;57.
Singh P, Alex JM, Bast F. Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer. Medical Oncology. 2014;31(1).
Knudsen L, Hansen BF, Jensen P, Pedersen TÅ, Vestergaard K, Schäffer L, Blagoev B, Oleksiewicz MB, Kiselyov VV, De Meyts P. Agonism and antagonism at the insulin receptor. PLoS One. 2013;7(12):e51972.
Khalid M, Alkaabi J, Khan MAB, Adem A.. Insulin signal transduction perturbations in insulin resistance. Int J Mol Sci. 2021;22(16):8590–8606.
Li Y, Pan H, Zhang X, Wang H, Liu S, Zhang H, Qian H, Wang L, Ying H.. Geniposide improves glucose homeostasis via regulating foxo1/pdk4 in skeletal muscle. J Agric Food Chem. 2019;67(16):4483–4492.
Sharma R, Kumari M, Prakash P, Gupta S, Tiwari S.. Phosphoenolpyruvate carboxykinase in urine exosomes reflect impairment in renal gluconeogenesis in early insulin resistance and diabetes. Am J Physiol Renal Physiol. 2020;318(3):F720–F731.
Mastrototaro L, Roden M.. Insulin resistance and insulin sensitizing agents. Metabolism. 2021;125:154892.
Sheikh Y, Chanu MB, Mondal G, Manna P, Chattoraj A, Deka DC, Talukdara NC, Borah JC. Procyanidin A2, an anti-diabetic condensed tannin extracted from Wendlandia glabrata, reduces elevated G-6-Pase and mRNA levels in diabetic mice and increases glucose uptake in CC1 hepatocytes and C1C12 myoblast cells. Royal Chem Soc. 2019;9:17211-17219.
Faizah S, Eriani K, Rosnizar. Effectiveness test of Diploknema oligomera extracts to the decrease in glucose levels in alloxan-induced BALB/c male mice. Nusantara Bioscience. 2023;15(2):143-148.
Lenzen S. The mechanisms of alloxan- and streptozotocin-induced Diabetes. Diabetologia. 2008;51(2):216-26.
Yohanna FT, Haruna WC, Yerima TS, Sodipo OA, Aliyu F. 2018. Phytochemical screening and Antidiabetic effect of ethanol extracts of Leptadenia hastata plant (Pers.) Decne) in alloxan-induced diabetic rats. Nigerian Journal of Pharmaceutical and Biomedical Research. 2018;3(1):22-27.
Jain DK, Arya RK. Anomalies in alloxan-induced diabetic model: It is better to standardize it first. Indian Journal of Pharmacology. 2011;43(1):91.
Chougale AD, Panaskar SN, Gurao PM, Arvindekar AU. Optimization of Alloxan Dose is Essential to Induce Stable Diabetes for Prolonged Period. Asian Journal of Biochemistry. 2007;2(6):402-408.
Aybar MJ, Sanchez Riera AN, Grau A, Sanchez SS. Hypoglycemic effect of the water extract of Smallanthus sonchifolius (yacon) leaves in normal and diabetic rats. J. Ethnopharmacol. 2001;74:125–132.
Petchi RR, Parasuraman S, Vijaya C. Antidiabetic and antihyperlipidemic effects of an ethanolic extract of the whole plant of Tridax procumbens (Linn.) in streptozotocin-induced diabetic rats. J. Basic Clin. Pharm. 2013;4:88–92.
Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: An overview. Avicenna J Med. 2020;10(4):174–188.
DOI (PDF): https://doi.org/10.24198/ijbp.v4i2.60782.g25794
Refbacks
- Saat ini tidak ada refbacks.
##submission.license.cc.by-nc4.footer##
IJBP by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License